(19)
(11) EP 4 461 312 A3

(12) EUROPEAN PATENT APPLICATION

(88) Date of publication A3:
22.01.2025 Bulletin 2025/04

(43) Date of publication A2:
13.11.2024 Bulletin 2024/46

(21) Application number: 24201758.0

(22) Date of filing: 15.09.2016
(51) International Patent Classification (IPC): 
C07K 16/22(2006.01)
A61K 39/00(2006.01)
A61K 39/395(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/22; A61K 2039/505; A61K 2039/545; C07K 2317/24; C07K 2317/33; C07K 2317/92; A61P 21/00; A61P 9/00
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 15.09.2015 US 201562219094 P

(62) Application number of the earlier application in accordance with Art. 76 EPC:
21170667.6 / 3922645
16774748.4 / 3350220

(71) Applicant: Scholar Rock, Inc.
Cambridge, MA 02142 (US)

(72) Inventors:
  • CARVEN, Gregory, J.
    Maynard, MA 01754 (US)
  • STRAUB, Michelle
    Yarmouth, ME 04096 (US)
  • DONOVAN, Adriana
    West Roxbury, MA 02132 (US)
  • TURNER, Katherine, Jane
    Acton, MA 01720 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF


(57) Aspects of the present disclosure relate to antibodies that specifically bind proMyostatin and/or latent Myostatin and uses thereof.







Search report



























Search report